pillbase.ru

Tabrecta

Active substance: capmatinib

capmatinib dihydrochloride monohydrate

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • TABRECTA
    TABLET, FILM COATED · CAPMATINIB HYDROCHLORIDE 200 mg/1
    0078-0716
    Novartis Pharmaceuticals Corporation
  • TABRECTA
    TABLET, FILM COATED · CAPMATINIB HYDROCHLORIDE 150 mg/1
    0078-0709
    Novartis Pharmaceuticals Corporation
  • capmatinib
    TABLET, FILM COATED · CAPMATINIB HYDROCHLORIDE 200 mg/1
    66828-0275
    Novartis Pharma Produktions GmbH
  • capmatinib
    TABLET, FILM COATED · CAPMATINIB HYDROCHLORIDE 150 mg/1
    66828-0317
    Novartis Pharma Produktions GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-01a8-7f13-8245-61478a167e7e,01a12091-6a3c-7828-984b-bb390ce1338d,01a12093-4180-766c-bc45-c615ad47160e,01a12095-6cce-7e54-9f4b-0df186d7a146;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004845
Registration status
Active
ATC code
L01EX17
Sources
  • product · EMA · EMEA/H/C/004845 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004845 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004845 · Verified 2026-10-09